Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VORTIOXETINE HYDROBROMIDE, with a corresponding US DMF Number 31492.
Remarkably, this DMF maintains an Active status since its submission on May 25, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 28, 2017, and payment made on June 06, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II